<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: Parasitic protozoans of the Cryptosporidium genus are intracellular <z:e sem="disease" ids="C0021832" disease_type="Disease or Syndrome" abbrv="">intestinal parasites</z:e> of mammals, causing <z:e sem="disease" ids="C0010418" disease_type="Disease or Syndrome" abbrv="">cryptosporidiosis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Clinically, <z:e sem="disease" ids="C0010418" disease_type="Disease or Syndrome" abbrv="">cryptosporidiosis</z:e> manifests as <z:hpo ids='HP_0011010'>chronic</z:hpo> diarrhoea </plain></SENT>
<SENT sid="2" pm="."><plain>Individuals with <z:e sem="disease" ids="C0947760" disease_type="Disease or Syndrome" abbrv="">immune disorders</z:e>, including those with <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, are at risk of symptomatic invasion </plain></SENT>
<SENT sid="3" pm="."><plain>THE AIM OF THE STUDY: Was the evaluation of Cryptosporidium sp. prevalence in patients with diagnosed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>MATERIAL AND METHODS: The studied group encompassed 87 patients with diagnosed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, undergoing surgery at the Department of General and Oncological Surgery, Pomeranian Medical University, in the years 2009-2010 </plain></SENT>
<SENT sid="5" pm="."><plain>Immunoenzymatic tests for Cryptosporidium sp. on faeces samples were performed with the use of commercial test kit, ProSpecT(Â®)Cryptosporidium Microplate Assay (Remel Inc) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The presence of Cryptosporidium sp. was found in 12.6% of studied patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The performed statistical analysis did not reveal any correlation between Cryptosporidium sp. <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and gender, age, <z:hpo ids='HP_0002664'>neoplasm</z:hpo> advancement stage as per Astler-Coller scale, <z:hpo ids='HP_0002664'>neoplasm</z:hpo> differentiation grade, or neoplastic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> localisation in relation to the splenic flexure </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: There was found high prevalence of Cryptosporidium sp. in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>It was comparable to the prevalence reported for patients with <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> </plain></SENT>
</text></document>